Search research articles
Contact Us
Filters
Showing results (11-20 of 267) with videos related to
Page
of 27
Sort By:
Molecular Cancer Therapeutics
|
June 30, 2011
Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools
Olaf Merkel, Frank Hamacher, Eveline Sifft, et al.
Future Oncology (London, England)
|
February 25, 2014
New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?
Peter Birner, Rupert Bartsch, Martin Schreiber, et al.
Stem Cell Reviews and Reports
|
January 22, 2010
Promising new sources for pluripotent stem cells
Christian Leeb, Marcin Jurga, Colin McGuckin, et al.
Mutation Research
|
January 27, 2009
Translational regulation mechanisms of AP-1 proteins
Paul Willi Vesely, Philipp Bernhard Staber, Gerald Hoefler, et al.
Swiss Medical Weekly
|
December 23, 2015
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
Jan Pencik, Robert Wiebringhaus, Martin Susani, et al.
Wiener Medizinische Wochenschrift (1946)
|
September 23, 2008
[Stem cells--cloning, plasticity, bioethic]
Pamina Pflegerl, Thomas Keller, Brigitte Hantusch, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
April 23, 2014
ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC
Anna Sophie Berghoff, Peter Birner, Berthold Streubel, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer
Brigitte Hantusch, Lukas Kenner, Vesna S Stanulović, et al.
Frontiers in Bioscience (Scholar Edition)
|
May 12, 2015
The role of AP-1 and epigenetics in ALCL
Ana-Iris Schiefer, Paul Vesely, Melanie R Hassler, et al.
Cell Cycle (Georgetown, Tex.)
|
January 29, 2011
Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis
Jennifer Jurkin, Gordin Zupkovitz, Sabine Lagger, et al.
Page
of 27
Search research articles
Search
Showing results (11-20 of 267) with videos related to
Sort By:
Page
of 27
Molecular Cancer Therapeutics
|
June 30, 2011
Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools
Olaf Merkel, Frank Hamacher, Eveline Sifft, et al.
Future Oncology (London, England)
|
February 25, 2014
New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?
Peter Birner, Rupert Bartsch, Martin Schreiber, et al.
Stem Cell Reviews and Reports
|
January 22, 2010
Promising new sources for pluripotent stem cells
Christian Leeb, Marcin Jurga, Colin McGuckin, et al.
Mutation Research
|
January 27, 2009
Translational regulation mechanisms of AP-1 proteins
Paul Willi Vesely, Philipp Bernhard Staber, Gerald Hoefler, et al.
Swiss Medical Weekly
|
December 23, 2015
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
Jan Pencik, Robert Wiebringhaus, Martin Susani, et al.
Wiener Medizinische Wochenschrift (1946)
|
September 23, 2008
[Stem cells--cloning, plasticity, bioethic]
Pamina Pflegerl, Thomas Keller, Brigitte Hantusch, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
April 23, 2014
ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC
Anna Sophie Berghoff, Peter Birner, Berthold Streubel, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer
Brigitte Hantusch, Lukas Kenner, Vesna S Stanulović, et al.
Frontiers in Bioscience (Scholar Edition)
|
May 12, 2015
The role of AP-1 and epigenetics in ALCL
Ana-Iris Schiefer, Paul Vesely, Melanie R Hassler, et al.
Cell Cycle (Georgetown, Tex.)
|
January 29, 2011
Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis
Jennifer Jurkin, Gordin Zupkovitz, Sabine Lagger, et al.
Page
of 27